Voxelotor for sickle cell disease
Voxelotor for sickle cell disease
Article:
Lancet Haematol. 2021 May;8(5):e306-e307. PMID: 33838114
Voxelotor in adolescents and adults with sickle cell disease (HOPE): long-term follow-up results of an international, randomised, double-blind, placebo-controlled, phase 3 trial.
Reviewer: Dr. Ezgi Atilgan